" class="no-js "lang="en-US"> Roche Archives - Medtech Alert
Friday, March 01, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Roche Showcases Commitment to Advancing Innovative Diagnostic Solutions

Roche announced today that it will be showcasing innovative laboratory solutions and digital diagnostics through […]

DiogenX Raises €27.5M Series A Financing to Advance its First-In-Class Treatment for Type 1 Diabetes

DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, […]

FDA Accepts Application for Roche’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s […]

Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study

Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]

Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease

Roche announced today that it has entered into a collaboration with Eli Lilly and Company […]

Roche launches Two New Antibodies to Identify Key Clinical Mutations in Patients with Brain Cancer

Roche announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and […]

Roche’s Vabysmo Rapidly Improved Vision and Reduced Retinal Fluid in People with Retinal Vein Occlusion (RVO)

Roche today announced positive new data from two global phase III studies, BALATON and COMINO, […]

Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics

Roche today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to […]

Roche Announces Positive Data from Global Phase III Programme for Crovalimab in PNH, a Rare Life-threatening Blood Condition

Roche has announced positive results from the global phase III COMMODORE 2 study, evaluating the […]

CARsgen Announces Collaboration Agreement with Roche to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer

CARsgen Therapeutics, a company focused on innovative therapies for the treatment of hematologic malignancies and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more